Finance

Beta
Lists
DRUG:NASDAQ
Bright Minds Biosciences Inc
$69.00
-7.38%
(-5.50) 1D
$69.00
0.00% (0.00)
After hours
Closed: Jun 5, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DRUG...
Open
$73.64
High
$73.64
Low
$67.04
Mkt. cap
940.02M
Avg. vol.
278.88K
Volume
712.34K
52-wk high
$123.75
52-wk low
$23.18
Beta
-5.38
Shares outstanding
9.79M
No. of employees
26
Open
$73.64
High
$73.64
Low
$67.04
Mkt. cap
940.02M
Avg. vol.
278.88K
Volume
712.34K
52-wk high
$123.75
52-wk low
$23.18
Beta
-5.38
Shares outstanding
9.79M
No. of employees
26
News stories
From sources across the web
Profile
Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York. Wikipedia
About Bright Minds Biosciences Inc
CEO-
Employees26
Founded2017
Headquarters-
SectorBiotechnology
Websitebrightmindsbio.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CAD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.69M
4.78M
5.66M
13.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
591.94K
749.11K
1.08M
2.23M
Operating expense
3.03M
5.79M
6.74M
15.28M
Total operating expenses
3.03M
5.79M
6.74M
15.28M
Operating income
-3.03M
-5.79M
-6.74M
-15.28M
Other non operating income
-12.52K
-123.93K
-154.22K
-42.48K
EBT including unusual items
-5.24M
-4.09M
-7.57M
-10.46M
EBT excluding unusual items
-5.24M
-4.09M
-7.57M
-10.46M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-257.87K
257.87K
-
-
Net income
-5.24M
-4.09M
-7.57M
-10.46M
Net profit margin
-
-
-
-
Earnings per share
-0.74
-0.58
-0.97
-1.09
Interest and investment income
476.23K
529.54K
818.26K
2.69M
Interest expense
-
-7.30K
-6.58K
-
Net interest expenses
476.23K
522.24K
811.69K
2.69M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer